This in turn lead to the activation of a signal transduction starting from the insulin receptor substrate (IRS), involving the phosphoinositide 3-kinase (PI3K) and Akt (PKB, protein kinase B) and inactivating the TSC Complex Subunit 2 (TSC2), known as a tumor suppressor. The gene discussed is AKT1; the disease is neoplasm.